Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2277 to 2326 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2277\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
regulator of chromosome condensation (cell cycle regulatory protein). [source:swissprot;acc:p18754]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
191.936\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
190.909\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00538\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2278\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger homeobox protein 1b (smad interacting protein 1) (smadip1) (hrihfb2411). [source:swissprot;acc:o60315]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2279\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor 8 (nil-2-a zinc finger protein) (negative regulator of il2). [source:swissprot;acc:p37275]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2280\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 7 (ec 3.4.25.1) (proteasome subunit rc6-1) (proteasome subunit xapc7). [source:swissprot;acc:o14818]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.793\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.657\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00537\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2281\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing coactivator subunit srm300; rna binding protein; at-rich element binding factor. [source:refseq;acc:nm\_016333]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
219.652\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.482\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00536\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2282\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor u2af 35 kda subunit (u2 auxiliary factor 35 kda subunit) (u2 snrnp auxiliary factor small subunit). [source:swissprot;acc:q01081]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2283\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 7-like (ec 3.4.25.1). [source:swissprot;acc:q8taa3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.676\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2284\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rna helicase-related protein; rna helicase-like protein; sf3b125 dead-box protein. [source:refseq;acc:nm\_007372]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
219.652\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.482\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2285\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor u2af 65 kda subunit (u2 auxiliary factor 65 kda subunit) (u2 snrnp auxiliary factor large subunit) (hu2af(65)). [source:swissprot;acc:p26368]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2286\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 2 (ec 1.14.13.8) (pulmonary flavin-containing monooxygenase 2) (fmo 2) (dimethylaniline oxidase 2) (fmo 1b1). [source:swissprot;acc:q99518]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.608\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.456\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00535\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2287\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phospholipase d1 (ec 3.1.4.4) (pld 1) (choline phosphatase 1) (phosphatidylcholine-hydrolyzing phospholipase d1) (hpld1). [source:swissprot;acc:q13393]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.475\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.376\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2288\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 1 (ec 1.14.13.8) (fetal hepatic flavin-containing monooxygenase 1) (fmo 1) (dimethylaniline oxidase 1). [source:swissprot;acc:q01740]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.607\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.458\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00533\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2289\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 4 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 4) (fmo 4) (dimethylaniline oxidase 4). [source:swissprot;acc:p31512]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.605\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00531\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2290\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myo-inositol 1-phosphate synthase a1. [source:refseq;acc:nm\_016368]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
200.158\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
201.213\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00527\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2291\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arsenical pump-driving atpase (ec 3.6.3.16) (arsenite-translocating atpase) (arsenical resistance atpase) (arsenite-transporting atpase) (arsa) (asna-i). [source:swissprot;acc:o43681]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2292\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-like protein gdx (ubiquitin-like protein 4). [source:swissprot;acc:p11441]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2293\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
large proline-rich protein bat3 (hla-b-associated transcript 3) (g3). [source:swissprot;acc:p46379]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2294\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 13b; apoptosis-stimulating protein of p53, 1. [source:refseq;acc:nm\_015316]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
162.331\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
163.187\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2295\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor suppressor p53-binding protein 2 (p53-binding protein 2) (53bp2) (bcl2-binding protein) (bbp). [source:swissprot;acc:q13625]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
162.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
163.712\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00523\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2296\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phospholipase d2 (ec 3.1.4.4) (pld 2) (choline phosphatase 2) (phosphatidylcholine-hydrolyzing phospholipase d2) (pld1c) (hpld2). [source:swissprot;acc:o14939]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.451\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00521\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2297\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
epsin 3. [source:refseq;acc:nm\_017957]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.153\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.284\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00518\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2298\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-like protein smt3c precursor (ubiquitin-homology domain protein pic1) (ubiquitin-like protein ubl1) (ubiquitin-related protein sumo-1) (gap modifying protein 1) (gmp1) (sentrin). [source:swissprot;acc:q93068]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
215.239\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.339\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00511\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2299\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
udp-glucose 6-dehydrogenase (ec 1.1.1.22) (udp-glc dehydrogenase) (udp-glcdh) (udpgdh). [source:swissprot;acc:o60701]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2300\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-ketoacyl-coa thiolase, peroxisomal precursor (ec 2.3.1.16) (beta- ketothiolase) (acetyl-coa acyltransferase) (peroxisomal 3-oxoacyl- coa thiolase). [source:swissprot;acc:p09110]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
191.563\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
192.541\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2301\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nicotinamide nucleotide adenylyltransferase 3; pyridine nucleotide adenylyltransferase 3. [source:refseq;acc:nm\_178177]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.392\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.498\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00509\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2302\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hydroxymethylglutaryl-coa synthase, mitochondrial precursor (ec 2.3.3.10) (hmg-coa synthase) (3-hydroxy-3-methylglutaryl coenzyme a synthase). [source:swissprot;acc:p54868]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
191.567\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
192.542\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2303\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-hydroxy-3-methylglutaryl-coenzyme a reductase (ec 1.1.1.34) (hmg-coa reductase). [source:swissprot;acc:p04035]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2304\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hydroxymethylglutaryl-coa synthase, cytoplasmic (ec 2.3.3.10) (hmg-coa synthase) (3-hydroxy-3-methylglutaryl coenzyme a synthase). [source:swissprot;acc:q01581]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2305\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
delta 1-pyrroline-5-carboxylate synthetase (p5cs) [includes: glutamate 5-kinase (ec 2.7.2.11) (gamma-glutamyl kinase) (gk); gamma-glutamyl phosphate reductase (gpr) (ec 1.2.1.41) (glutamate-5-semialdehyde dehydrogenase) (glutamyl-gamma-semialdehyde dehydrogenase)]. [source:swissprot;acc:p54886]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.392\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.498\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2306\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acetyl-coa acetyltransferase, mitochondrial precursor (ec 2.3.1.9) (acetoacetyl-coa thiolase) (t2). [source:swissprot;acc:p24752]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
191.571\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
192.544\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00508\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2307\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase type ii-alpha regulatory chain. [source:swissprot;acc:p13861]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.554\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.467\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00507\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2308\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase pkx1 (ec 2.7.1.-). [source:swissprot;acc:p51817]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.543\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
214.459\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00505\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2309\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase, gamma-catalytic subunit (ec 2.7.1.37) (pka c-gamma). [source:swissprot;acc:p22612]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.542\vspace{3pt}}&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2310\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin. [source:swissprot;acc:p02248]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.617\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.529\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2311\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase, beta-catalytic subunit (ec 2.7.1.37) (pka c-beta). [source:swissprot;acc:p22694]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
215.542\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
214.459\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2312\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase, alpha-catalytic subunit (ec 2.7.1.37) (pka c-alpha). [source:swissprot;acc:p17612]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2313\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase type ii-beta regulatory chain. [source:swissprot;acc:p31323]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.529\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.449\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00504\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2314\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2-17 kda 2 (ec 6.3.2.19) (ubiquitin- protein ligase) (ubiquitin carrier protein) (e2(17)kb 2). [source:swissprot;acc:p51669]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
194.743\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
195.708\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00496\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2315\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acetyl-coa carboxylase 2 (ec 6.4.1.2) (acc-beta) [includes: biotin carboxylase (ec 6.3.4.14)]. [source:swissprot;acc:o00763]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
194.825\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
195.787\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00494\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2316\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 12 (26s proteasome regulatory subunit p55). [source:swissprot;acc:o00232]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.241\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.311\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00493\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2317\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 6 (ec 3.1.3.16) (pp6). [source:swissprot;acc:o00743]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
194.834\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
195.794\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2318\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sporulation-induced transcript 4-associated protein. [source:refseq;acc:nm\_018312]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2319\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acetyl-coa carboxylase 1 (ec 6.4.1.2) (acc-alpha) [includes: biotin carboxylase (ec 6.3.4.14)]. [source:swissprot;acc:q13085]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
194.842\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
195.8\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00492\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2320\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rad54-like protein; rad54 homolog. [source:refseq;acc:nm\_003579]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.292\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.218\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2321\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tetratricopeptide repeat protein 4 (my044 protein). [source:swissprot;acc:o95801]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
203.909\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.925\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00485\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2322\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
trans-prenyltransferase; polyprenyl pyrophosphate synthetase. [source:refseq;acc:nm\_014317]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
236.023\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
234.905\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00476\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2323\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
asparaginyl-trna synthetase, cytoplasmic (ec 6.1.1.22) (asparagine-- trna ligase) (asnrs). [source:swissprot;acc:o43776]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
192.773\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
193.691\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2324\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit beta type 1 (ec 3.4.25.1) (proteasome component c5) (macropain subunit c5) (multicatalytic endopeptidase complex subunit c5) (proteasome gamma chain). [source:swissprot;acc:p20618]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.129\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.129\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00474\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2325\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
methionyl-trna formyltransferase, mitochondrial precursor (ec 2.1.2.9) (mtfmt). [source:swissprot;acc:q96dp5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.728\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.685\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00473\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2326\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 4 (ec 2.7.1.-) (map kinase kinase 4) (jnk activating kinase 1) (c-jun n- terminal kinase kinase 1) (jnkk) (sapk/erk kinase 1) (sek1). [source:swissprot;acc:p45985]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.076\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00468\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/